The emerging role of miR-10 family in gastric cancer

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.
   PubMed Web of Science ®Google Scholar
• Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–279.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Seeneevassen L, Bessede E, Megraud F, et al. Gastric cancer: advances in carcinogenesis research and new therapeutic strategies. Int J Mol Sci. 2021;22:22.
   Web of Science ®Google Scholar
• Olnes MJ, Martinson HA. Recent advances in immune therapies for gastric cancer. Cancer Gene Ther. 2021. DOI:10.1038/s41417-021-00310-y
   PubMed Web of Science ®Google Scholar
• Ng SP, Leong T. Role of radiation therapy in gastric cancer. Ann Surg Oncol. 2021. DOI:10.1245/s10434-021-09639-y
   Web of Science ®Google Scholar
• Yoneda A, Kuroki T, Eguchi S. Immunotherapeutic advances in gastric cancer. Surg Today. 2021. DOI:10.1007/s00595-021-02236-2
   PubMedGoogle Scholar
• Irino T, Matsuda S, Wada N, et al. Essential updates 2019/2020: perioperative and surgical management of gastric cancer. Ann Gastroenterol Surg. 2021;5:162–172.
   PubMed Web of Science ®Google Scholar
• Kawazoe A, Shitara K, Boku N, et al. Current status of immunotherapy for advanced gastric cancer. Jpn J Clin Oncol. 2021;51:20–27.
   PubMed Web of Science ®Google Scholar
• Sasahara M, Kanda M, Kodera Y. Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer. Histol Histopathol. 2021;18326. DOI:10.14670/HH-18-326
   PubMedGoogle Scholar
• Slagter AE, Vollebergh MA, Jansen EPM, et al. Towards personalization in the curative treatment of gastric cancer. Front Oncol. 2020;10:614907.
   PubMed Web of Science ®Google Scholar
• Petrillo A, Smyth EC. Biomarkers for precision treatment in gastric cancer. Visc Med. 2020;36:364–372.
   PubMed Web of Science ®Google Scholar
• Ramezankhani R, Solhi R, Es HA, et al. Novel molecular targets in gastric adenocarcinoma. Pharmacol Ther. 2021;220:107714.
   PubMed Web of Science ®Google Scholar
• Tabibzadeh A, Tameshkel FS, Moradi Y, et al. Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis. Sci Rep. 2020;10:18713.
   PubMed Web of Science ®Google Scholar
• Baghery Saghchy Khorasani A, Pourbagheri-Sigaroodi A, Pirsalehi A, et al. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions. Eur J Pharmacol. 2021;898:173983.
   PubMed Web of Science ®Google Scholar
• Li Z, Lu M, Zhou Y, et al. Role of long non-coding RNAs in the chemoresistance of gastric cancer: a systematic review. Onco Targets Ther. 2021;14:503–518.
   PubMed Web of Science ®Google Scholar
• Shrestha S, Hsu SD, Huang WY, et al. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med. 2014;3:878–888.
   PubMed Web of Science ®Google Scholar
• Han BW, Li ZH, Liu SF, et al. A comprehensive review of microRNA-related polymorphisms in gastric cancer. Genet Mol Res. 2016;15. DOI:10.4238/gmr.15028289
   Web of Science ®Google Scholar
• Ouyang J, Xie Z, Lei X, et al. Clinical crosstalk between microRNAs and gastric cancer. Int J Oncol. 2021;58:1.
   PubMed Web of Science ®Google Scholar
• Kipkeeva F, Muzaffarova T, Korotaeva A, et al. MicroRNA in gastric cancer development: mechanisms and biomarkers. Diagnostics (Basel). 2020;10:10.
   Google Scholar
• Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20:21–37.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203–222.
   PubMed Web of Science ®Google Scholar
• Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 2016;17:719–732.
   PubMed Web of Science ®Google Scholar
• Brennan GP, Henshall DC. MicroRNAs as regulators of brain function and targets for treatment of epilepsy. Nat Rev Neurol. 2020;16:506–519.
   PubMed Web of Science ®Google Scholar
• Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20:5–20.
   PubMed Web of Science ®Google Scholar
• Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21:22–36.
   PubMed Web of Science ®Google Scholar
• Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847–865.
   PubMed Web of Science ®Google Scholar
• Giuppi M, La Salvia A, Evangelista J, et al. The role and expression of angiogenesis-related miRNAs in gastric cancer. Biology (Basel). 2021;10. DOI:10.3390/biology10020146
   Google Scholar
• Liu X, Ma R, Yi B, et al. MicroRNAs are involved in the development and progression of gastric cancer. Acta Pharmacol Sin. 2021;42:1018–1026.
   Web of Science ®Google Scholar
• Weidle UH, Birzele F, Nopora A. microRNAs promoting growth of gastric cancer xenografts and correlation to clinical prognosis. Cancer Genomics Proteomics. 2021;18:1–15.
   PubMed Web of Science ®Google Scholar
• Elgeshy KM, Abdel Wahab AHA. Role, significance and association of microRNA-10a/b in physiology of cancer. Microrna. 2020. DOI:10.2174/2211536609666201026155519
   PubMedGoogle Scholar
• Sheedy P, Medarova Z. The fundamental role of miR-10b in metastatic cancer. Am J Cancer Res. 2018;8:1674–1688.
   PubMed Web of Science ®Google Scholar
• Tehler D, Hoyland-Kroghsbo NM, Lund AH. The miR-10 microRNA precursor family. RNA Biol. 2011;8:728–734.
   PubMed Web of Science ®Google Scholar
• Lund AH. miR-10 in development and cancer. Cell Death Differ. 2010;17:209–214.
   PubMed Web of Science ®Google Scholar
• Huang Q, Song Q, Zhong W, et al. MicroRNA-10b and the clinical outcomes of various cancers: a systematic review and meta-analysis. Clin Chim Acta. 2017;474:14–22.
   PubMed Web of Science ®Google Scholar
• Mei L, Lu Z, Shen Z, et al. The prognostic and diagnostic values of MicroRNA-10b in gastric cancer: a comprehensive study based on meta-analysis and TCGA database. Medicine (Baltimore). 2020;99:e20508.
   PubMed Web of Science ®Google Scholar
• Balatti V, Oghumu S, Bottoni A, et al. MicroRNA profiling of salivary duct carcinoma versus Her2/Neu overexpressing breast carcinoma identify miR-10a as a putative breast related oncogene. Head Neck Pathol. 2019;13:344–354.
   PubMed Web of Science ®Google Scholar
• Bi L, Sun L, Jin Z, et al. MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia. Oncol Lett. 2018;15:5611–5619.
   PubMed Web of Science ®Google Scholar
• Zhai L, Li Y, Lan X, et al. MicroRNA-10a-5p suppresses cancer proliferation and division in human cervical cancer by targeting BDNF. Exp Ther Med. 2017;14:6147–6151.
   PubMed Web of Science ®Google Scholar
• Bourguignon LY, Wong G, Shiina M. Up-regulation of histone methyltransferase, DOT1L, by matrix hyaluronan promotes MicroRNA-10 expression leading to tumor cell invasion and chemoresistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 2016;291:10571–10585.
   PubMed Web of Science ®Google Scholar
• Pereira AL, Magalhaes L, Moreira FC, et al. Epigenetic field cancerization in gastric cancer: microRNAs as promising biomarkers. J Cancer. 2019;10:1560–1569.
   PubMed Web of Science ®Google Scholar
• Chen W, Tang Z, Sun Y, et al. miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes. Exp Ther Med. 2012;3:351–356.
   PubMed Web of Science ®Google Scholar
• Lu Y, Wei G, Liu L, et al. Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis. Oncol Lett. 2017;13:1131–1136.
   PubMed Web of Science ®Google Scholar
• Jia H, Zhang Z, Zou D, et al. MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells. PLoS One. 2014;9:e88057.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Zhang Y, et al. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010;59:579–585.
   PubMed Web of Science ®Google Scholar
• Wang YY, Ye ZY, Zhao ZS, et al. Clinicopathologic significance of miR-10b expression in gastric carcinoma. Hum Pathol. 2013;44:1278–1285.
   PubMed Web of Science ®Google Scholar
• Obermannova R, Redova-Lojova M, Vychytilova-Faltejskova P, et al. Tumor expression of miR-10b, miR-21, miR-143 and miR-145 is related to clinicopathological features of gastric cancer in a central european population. Anticancer Res. 2018;38:3719–3724.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xu Z, Yuan F, et al. Correlation of expression levels of micro ribonucleic Ccid-10b (miR-10b) and micro ribonucleic acid-181b (miR-181b) with gastric cancer and its diagnostic significance. Med Sci Monit. 2018;24:7988–7995.
   PubMed Web of Science ®Google Scholar
• Yan T, Wang X, Wei G, et al. Exosomal miR-10b-5p mediates cell communication of gastric cancer cells and fibroblasts and facilitates cell proliferation. J Cancer. 2021;12:2140–2150.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Han T, Feng D, et al. Screening of non-invasive miRNA biomarker candidates for metastasis of gastric cancer by small RNA sequencing of plasma exosomes. Carcinogenesis. 2020;41:582–590.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhu J, Cao H, et al. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol. 2012;40:1553–1560.
   PubMed Web of Science ®Google Scholar
• Wang YY, Li L, Ye ZY, et al. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer. World J Surg Oncol. 2015;13:259.
   PubMed Web of Science ®Google Scholar
• Ma Z, Chen Y, Min L, et al. Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma. Int J Clin Exp Pathol. 2015;8:5071–5079.
   PubMed Web of Science ®Google Scholar
• Nishida N, Yamashita S, Mimori K, et al. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Ann Surg Oncol. 2012;19:3065–3071.
   PubMed Web of Science ®Google Scholar
• Ouyang M, Li Y, Ye S, et al. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS One. 2014;9:e96228.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Ginnebaugh KR, Yin S, et al. Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4. BMC Cancer. 2015;15:540.
   PubMed Web of Science ®Google Scholar
• Wu K, Hu Y, Yan K, et al. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARgamma in esophageal cancer. J Cell Physiol. 2020;235:1247–1258.
   PubMed Web of Science ®Google Scholar
• Tan WX, Sun G, Shangguan MY, et al. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling. Sci Rep. 2020;10:14768.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu X, Li Z, et al. microRNA expression profiling in multidrug resistance of the 5Fuinduced SGC7901 human gastric cancer cell line. Mol Med Rep. 2013;7:1506–1510.
   PubMed Web of Science ®Google Scholar
• Zhang X, Gu G, Li X, et al. Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b. Cell Cycle. 2020;19:2530–2537.
   PubMed Web of Science ®Google Scholar
• Xiao S, Zhou L. Gastric stem cells: physiological and pathological perspectives. Front Cell Dev Biol. 2020;8:571536.
   PubMed Web of Science ®Google Scholar
• Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, et al. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation. EMBO Rep. 2016;17:648–658.
   PubMed Web of Science ®Google Scholar
• Fomeshi MR, Ebrahimi M, Mowla SJ, et al. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells. Cell Mol Biol Lett. 2015;20:448–465.
   PubMed Web of Science ®Google Scholar
• Bakhshi M, Asadi J, Ebrahimi M, et al. Increased expression of miR-146a, miR-10b, and miR-21 in cancer stem-like gastro-spheres. J Cell Biochem. 2019;120:16589–16599.
   PubMed Web of Science ®Google Scholar
• Kim K, Lee HC, Park JL, et al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics. 2011;6:740–751.
   PubMed Web of Science ®Google Scholar
• Li Z, Lei H, Luo M, et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer. 2015;18:43–54.
   PubMed Web of Science ®Google Scholar
• Hu G, Shi Y, Zhao X, et al. CBFbeta/RUNX3-miR10b-TIAM1 molecular axis inhibits proliferation, migration, and invasion of gastric cancer cells. Int J Clin Exp Pathol. 2019;12:3185–3196.
   PubMed Web of Science ®Google Scholar
• Ma L, Reinhardt F, Pan E, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010;28:341–347.
   PubMed Web of Science ®Google Scholar
• Monroig-Bosque PDC, Shah MY, Fu X, et al. OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep. 2018;8:13106.
   PubMed Web of Science ®Google Scholar
• Ki J, Lee HY, Son HY, et al. Sensitive plasmonic detection of miR-10b in biological samples using enzyme-assisted target recycling and developed LSPR probe. ACS Appl Mater Interfaces. 2019;11:18923–18929.
   PubMed Web of Science ®Google Scholar